Results 191 to 200 of about 2,906,691 (234)

Hepatic Cytoreductive Surgery for Neuroendocrine Cancer

Surgical Oncology Clinics of North America, 2007
Patients with gut-based metastatic neuroendocrine tumors (NET) often present late in the course of their slowly progressive disease, when cancer has extended beyond the point of reasonable expectation for surgical cure. At this stage of disease, the tumor's overwhelming hormonal production often significantly impairs the patient's quality of life ...
Byron E, Wright, Chris C, Lee, Anton J, Bilchik   +2 more
openaire   +2 more sources

Cytoreductive surgery for recurrent ovarian cancer

Current Opinion in Obstetrics & Gynecology, 2007
The issue facing clinicians managing ovarian cancer has evolved over the past three decades from treatment for cure and subsequently palliation, to prolongation of survival for most patients. The purpose of this paper is to review the data, rationale, and issues surrounding cytoreductive surgery in recurrent ovarian cancer and its potential role in ...
Jan, Hauspy, Allan, Covens
openaire   +2 more sources

Advanced cytoreductive surgery: Asia Pacific perspective

Gynecologic Oncology, 2009
The thoroughness of cytoreductive surgery is the largest contributor to survival for patients with advanced ovarian and primary peritoneal carcinoma. For many years the surgery undertaken by Gynaecologic Oncologists has been tailored to match their surgical training.
Crandon, Alexander J., Obermair, Andreas
openaire   +3 more sources

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

European Journal of Surgical Oncology, 2018
BACKGROUND At present, selected patients with resectable colorectal peritoneal metastases (CRC-PM) are increasingly treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
M. Bushati, K. Rovers, A. Sommariva, P. Sugarbaker, D. L. Morris, Y. Yonemura, Claudio Quadros, S. P. Somashekhar, W. Ceelen, Pierre Dubé, Yan Li, V. Verwaal, O. Glehen, P. Piso, J. Spiliotis, M. Teo, S. González-Moreno, P. Cashin, K. Lehmann, M. Deraco, B. Moran, I. Hingh   +21 more
semanticscholar   +1 more source

[Cytoreductive surgery and immunotherapy].

Georgian medical news, 2007
The aim of the article was to treat Pliss lymphosarcoma by means of Cytoreductive surgery to improve patient outcomes by taking into consideration the dynamics of Blood Auto-Proteolytic Activity (BAPA). In rats suffering from tumour proves to be obvious that higher the BAPA, more intensive is the process of invasive growth of tumour.
M D, Samsoniia, E E, Lesnovskaia, M A, Kandelaki   +2 more
openaire   +1 more source

Cytoreductive surgery in peritoneal carcinomatosis

Journal of Visceral Surgery, 2021
J, Arquillière, O, Glehen, G, Passot
openaire   +2 more sources

Secondary Cytoreductive Surgery

2022
Thaïs Baert, Dennis S. Chi, Philipp Harter, Andreas du Bois   +3 more
openaire   +1 more source

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

BJA Education, 2021
S, Durnford, L, Boss, J, Bell
openaire   +2 more sources

Cytoreductive Surgery for Relapsed Ovarian Cancer

New England Journal of Medicine, 2022
Tomer, Meirson, David, Bomze, Gal, Markel   +2 more
openaire   +2 more sources

Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis

Surgical Endoscopy, 2020
L. Rodriguez-Ortiz, Á. Arjona-Sánchez, M. Ibáñez-Rubio, J. Sánchez-Hidalgo, Á. Casado-Adam, S. Rufián-Peña, J. Briceño-Delgado   +6 more
semanticscholar   +1 more source